Home » Newsletters » BioWorld Science

BioWorld Science

Sep. 29, 2014

View Archived Issues

The effect of bisphosphonate compounds in animal models of acute colitis

Recessive variant found in PCD deficiency with MODY-like diabetes

Invion updates on ongoing phase II trial of nadolol in mild asthma

Eutropics receives NCI contract to develop predictive tests for personalized AML treatment

Lipocine reports topline results from phase III trial of LPCN-1021

BerGenBio granted Wellcome Trust award for cancer development program

AstraZeneca discloses new FGFR-4 inhibitors

Reduced HYAL2 gene methylation in blood correlated with breast cancer

Safety and pharmacokinetics of ABT-767 in BRCA1 and BRCA2 germline tumors

FDA approves Vitekta

CHMP recommends approval of aclidinium bromide/formoterol fumarate

EMA recommends ketoconazole for approval in Cushing's syndrome

EMA committee recommends approval of Moventig

Roche divulges novel CB2 receptor agonists

Allergan discloses novel S1P1 receptor ligands

Roche discloses new agents for HCV infection

Genzyme presents promising data from 3-year follow up of CARE-MS I

New LRRK2 inhibitors disclosed by Merck & Co.

Application filed for marketing approval of remestemcel-L in Japan

Novartis applies for Japanese approval of panobinostat

EMA committee hands down positive opinion on Trulicity

FDA approves Iluvien for diabetic macular edema

Harvoni recommended for the treatment of chronic hepatitis C

EMA committee recommends European approval of Cyramza

Lixiana approved in Japan for additional indications

Signifor recommended by CHMP to treat patients with acromegaly

Boehringer Ingelheim's nintedanib receives positive opinion for second-line therapy of NSCLC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...